Zlatanic J, Korelitz B I, Wisch N, Kim P, Ammirati M, Schwarz S, Gruenstein S, Lipsey L
Department of Medicine, Lenox Hill Hospital, New York University School of Medicine, New York 10021, USA.
Am J Gastroenterol. 1997 Dec;92(12):2285-8.
Different hematologic abnormalities are often encountered in patients with inflammatory bowel disease. Among them anemia, leukocytosis, and thrombocytosis are commonly seen. Leukopenia and thrombocytopenia are observed mostly as a side effect of therapy, particularly with use of immunosuppressive drugs. Immune thrombocytopenic purpura is rarely reported in association with inflammatory bowel disease. We present two cases with combination of these entities along with a literature review and treatment options. Immune thrombocytopenic purpura in these patients presented as an extraintestinal manifestation of inflammatory bowel disease mediated by a disturbance of the immune system.
炎症性肠病患者常出现不同的血液学异常。其中,贫血、白细胞增多和血小板增多较为常见。白细胞减少和血小板减少主要是治疗的副作用,尤其是使用免疫抑制药物时。免疫性血小板减少性紫癜与炎症性肠病相关的报道很少。我们报告两例这些病症合并出现的病例,并进行文献综述及治疗方案探讨。这些患者的免疫性血小板减少性紫癜表现为炎症性肠病的肠外表现,由免疫系统紊乱介导。